financetom
Business
financetom
/
Business
/
South Korea Unveils About $19 Billion Package for Chip Industry
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
South Korea Unveils About $19 Billion Package for Chip Industry
May 23, 2024 6:33 AM

09:13 AM EDT, 05/23/2024 (MT Newswires) -- South Korea has unveiled a 26 trillion won ($19.09 billion) package to support its semiconductor market, multiple media outlets reported Thursday, citing the country's President Yoon Suk Yeol as saying in a meeting with government officials.

A 17 trillion won package was planned through Korea Development Bank for chip producers and suppliers to invest in semiconductor infrastructure, the outlets reported, citing the president.

South Korea's share in the international fabless industry - an industry term for a semiconductor company without a production line - is around 1%, the outlets said, citing Yoon.

"As we all know, semiconductors are a field where all-out national warfare is underway. Win or lose, that depends on who can make cutting-edge semiconductors first," Reuters quoted Yoon as saying to officials

The global fabless sector is dominated by Nvidia ( NVDA ) , while there is also a gap among local chip producers and leading contract chip manufacturers like Taiwan Semiconductor Manufacturing Company ( TSM ) , the outlets said, citing Yoon.

South Korea President Yoon's Office could not be immediately reached for comment by MT Newswires.

Nvidia's ( NVDA ) stock rose nearly 7% in recent Thursday premarket activity, while Taiwan Semiconductor Manufacturing's ( TSM ) shares were up nearly 3%.

Price: 1,014.83, Change: +65.33, Percent Change: +6.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada Nickel's NetZero Metals Awards Engineering Contracts, Advances Engineering Studies On Two Processing Facilities
Canada Nickel's NetZero Metals Awards Engineering Contracts, Advances Engineering Studies On Two Processing Facilities
Apr 17, 2024
09:24 AM EDT, 04/17/2024 (MT Newswires) -- Canada Nickel Co. Inc. ( CNIKF ) on Wednesday said its subsidiary, NetZero Metals had awarded two engineering contracts to SMS group, Metso and Ausenco Engineering Canada ULC. NetZero Metals is developing two processing facilities -- a nickel processing facility and a stainless steel and alloy production facility in the Timmins Nickel District....
Bloom Energy Names Daniel Berenbaum Chief Financial Officer
Bloom Energy Names Daniel Berenbaum Chief Financial Officer
Apr 17, 2024
09:14 AM EDT, 04/17/2024 (MT Newswires) -- Bloom Energy ( BE ) said Wednesday it has named Daniel Berenbaum chief financial officer, effective April 29. Berenbaum will succeed Greg Cameron, who will remain with Bloom Energy ( BE ) until the middle of May, the company said. Berenbaum previously served as National Instruments' chief financial officer, Bloom Energy ( BE...
Berry Global, Glatfelter Business Combination's HSR Waiting Period Expires
Berry Global, Glatfelter Business Combination's HSR Waiting Period Expires
Apr 17, 2024
09:27 AM EDT, 04/17/2024 (MT Newswires) -- Berry Global ( BERY ) and Glatfelter ( GLT ) said Wednesday the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its proposed business combination has expired, allowing a transaction to proceed. Earlier this year on the Feb. 7, Berry and Glatfelter ( GLT ) entered a deal under which Berry...
GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix
GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix
Apr 17, 2024
09:18 AM EDT, 04/17/2024 (MT Newswires) -- GSK (GSK) on Wednesday reported positive results from phase 3 trials for gepotidacin, an oral antibiotic to treat urogenital gonorrhea, and Shingrix, its shingles vaccine. The drug maker said gepotidacin achieved a 92.6% microbiological success rate and was non-inferior to the leading combination treatment and that safety and tolerability were consistent with phase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved